BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development
Provided By GlobeNewswire
Last update: Jul 7, 2025
RESEARCH TRIANGLE PARK, N.C., July 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the appointment of Babar Ghias as chief financial officer (CFO) and head of corporate development.
Read more at globenewswire.com8.3
-0.05 (-0.6%)
Find more stocks in the Stock Screener
BCRX Latest News and Analysis
